Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00−0.06 (-6.10%)
Close on Nov 17, 2026Market cap $35.42MP/E –Yield –
Skye Bioscience price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Skye Bioscience's price to book ratio was 17.7× on Jul 31, 2026, against 14.9× a year earlier. Over the last 4 years it ranged from 5.7× to 267.0×, with a median of 22.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 17.7× | +12.1 |
| 2025 | Dec 31, 2025 | 5.7× | −3.4 |
| 2024 | Dec 31, 2024 | 9.1× | −149.3 |
| 2023 | Dec 29, 2023 | 158.4× | +109.0 |
| 2022 | Jul 29, 2022 | 49.4× | +25.4 |
| 2021 | Dec 31, 2021 | 24.0× | −19.2 |
| 2020 | Dec 31, 2020 | 43.2× | – |
See a number that looks wrong?